Infectious Diseases News and Research

RSS

Study: sdNVP can lead to HIV treatment failure in women receiving drug to prevent infant infection

A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the increased risk of failure could only be detected in women who began full HIV treatment within about a year after receiving sdNVP.

16 Feb 2010

Critical Conditions wins Mom's Choice Awards for best health/safety book of 2010

Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive by author Martine Ehrenclou, MA, has been awarded its 14th book award by Mom's Choice Awards for best health/safety book of 2010. http://www.momschoiceawards.com/celebrate09.php

12 Feb 2010

HIV transmission among male partners: CFAR scientists discover origin of strains

A team of scientists, led by a virologist from the University of California, San Diego's Center for AID Research (CFAR), has discovered the origin of strains of human immunodeficiency virus (HIV) among men who have sex with men. The study, which may be important in developing prevention strategies for HIV, will appear in Science Translational Medicine on February 10, 2010.

12 Feb 2010

Blood test to detect elevated levels of antibodies unique to Alzheimer’s disease developed

OPKO Health, Inc. today announced the development of a simple diagnostic blood test for Alzheimer’s disease. The test, designed to detect elevated levels of antibodies unique to Alzheimer’s disease, was approximately 95% accurate in initial testing.

12 Feb 2010

New screening system developed to discover molecules that block HCV life cycle

A newly designed system of identifying molecules for treating hepatitis C should enable scientists to discover novel and effective therapies for the dangerous and difficult-to-cure disease of the liver, says Zhilei Chen, a Texas A&M University assistant professor of chemical engineering who helped develop the screening system.

12 Feb 2010

Fourth-quarter and full-year 2009 results announced by Quidel

Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today financial results for the fourth quarter and full year ended December 31, 2009.

12 Feb 2010

Emory-UGA IPIRC to host symposium on H1N1 virus

The Emory - University of Georgia Influenza Pathogenesis and Immunology Research Center will host a symposium April 18 - 20 at the Emory Conference Center featuring an international roster of speakers.

11 Feb 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir ® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients.

11 Feb 2010

PAREXEL International, Proteome Sciences form biomarker alliance

PAREXEL International Corporation, a leading global biopharmaceutical services provider, and Proteome Sciences plc, a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development. PAREXEL is using Proteome Sciences' PS Biomarker Services™ protein and peptide biomarker capabilities to support biopharmaceutical companies in making earlier assessments of new compounds in development.

From Parexel 11 Feb 2010

NCCID to host consultation with national and international experts to discuss ways to fight superbugs

The National Collaborating Centre for Infectious Diseases (NCCID) is hosting a consultation with national and international experts in Winnipeg on February 10th and 11th, 2010 to discuss ways to fight the threat posed by "superbugs," or bacteria that are increasingly resistant to conventional treatment with antibiotics.

11 Feb 2010

Haitian death toll climbs to 230,000, government says

The death toll from the Jan. 12 earthquake in Haiti has risen to 230,000, Marie-Laurence Jocelyn Lassegue, the country's communications minister, said on Tuesday, the Associated Press reports.

11 Feb 2010

Catalysis Foundation for Health to discover new TB biomarkers with $5M Bill & Melinda Gates Foundation grant

The Catalysis Foundation for Health (Catalysis), a 501 (c) (3) non-profit entity dedicated to developing sustainable diagnostics for the developing world, announced today that it has received a $5 million grant from the Bill & Melinda Gates Foundation. The grant money will be used to discover new tuberculosis (TB) biomarkers that can be used to improve diagnostic tests and potentially develop more effective TB treatments.

10 Feb 2010

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".

10 Feb 2010

PolyMedix provides overview of its 2010 clinical milestones

PolyMedix, Inc. (www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010 clinical milestones in a presentation by President & C.E.O., Nicholas Landekic at the 2010 BIO CEO & Investor Conference.

10 Feb 2010

Antimalarial medicines in African countries are substandard, says QAMSA study

The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.

10 Feb 2010

Measles vaccine does not increase risk of autism in children, reveals Polish study

As a pivotal paper linking childhood vaccinations to autism is discredited, a new study finds no evidence that the measles vaccine—given alone or as part of a combined measles, mumps, and rubella (MMR) vaccine—increases the risk of autism in children. The study appears in The Pediatric Infectious Disease Journal (www.pidj.com), published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

10 Feb 2010

G7 forgives Haiti's bilateral loans to support aid effort

At a press conference on Saturday, "Canadian Finance Minister Jim Flaherty said he and his G-7 colleagues would forgive bilateral loans extended to poverty-stricken Haiti, which estimates it could have lost 200,000 residents in the major earthquake that hit last month," Dow Jones Newswires reports.

10 Feb 2010

Loyola University Chicago offers new research-intensive program for healthcare industry

Registration is underway for Loyola University Chicago's new infectious disease & immunology master's degree program that will prepare graduates for challenging health-related positions in government, research and private industry.

10 Feb 2010

NIAID awards Tulane University over $15M to develop Lassa fever vaccine and treatment

The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

10 Feb 2010

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

OlFactor Laboratories, Inc., a majority owned subsidiary of Avisio, Inc. acquired an exclusive license to patented technology from UC Riverside.

10 Feb 2010

Infectious Diseases News and Research

Study: sdNVP can lead to HIV treatment failure in women receiving drug to prevent infant infection

Critical Conditions wins Mom's Choice Awards for best health/safety book of 2010

HIV transmission among male partners: CFAR scientists discover origin of strains

Blood test to detect elevated levels of antibodies unique to Alzheimer’s disease developed

New screening system developed to discover molecules that block HCV life cycle

Fourth-quarter and full-year 2009 results announced by Quidel

Emory-UGA IPIRC to host symposium on H1N1 virus

FDA grants approval for Abbott's antiretroviral medication Norvir

PAREXEL International, Proteome Sciences form biomarker alliance

NCCID to host consultation with national and international experts to discuss ways to fight superbugs

Haitian death toll climbs to 230,000, government says

Catalysis Foundation for Health to discover new TB biomarkers with $5M Bill & Melinda Gates Foundation grant

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

PolyMedix provides overview of its 2010 clinical milestones

Antimalarial medicines in African countries are substandard, says QAMSA study

Measles vaccine does not increase risk of autism in children, reveals Polish study

G7 forgives Haiti's bilateral loans to support aid effort

Loyola University Chicago offers new research-intensive program for healthcare industry

NIAID awards Tulane University over $15M to develop Lassa fever vaccine and treatment

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News